Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Rosenblum

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Clinical and Translational Science|March 2, 2012
Access to core facilities and other research resources provided by the Clinical and Translational Science AwardsDaniel Rosenblum
Current Opinion in Genetics & Development|April 23, 2022
Epithelial-immune crosstalk in health and diseaseDaniel Rosenblum, Shruti Naik
Chest|September 8, 2011
The role of the clinical and translational science awards program in improving the quality and efficiency of clinical researchDaniel Rosenblum, Barbara Alving
Cell Stem Cell|April 2, 2021
New dog, old tricks: Developmental programs resurface in inflammationDaniel Rosenblum, Shruti Naik
Substance Use & Misuse|March 27, 2013
Did the Taliban's opium eradication campaign cause a decline in HIV infections in Russia?Daniel Rosenblum, Maggie Jones
Cancer Letters|August 15, 2013
Omics-based nanomedicine: the future of personalized oncologyDaniel Rosenblum, Dan Peer
Nature Biotechnology|November 13, 2021
RNA delivery with a human virus-like particleAnna Gutkin, Daniel Rosenblum, Dan Peer
Drug and Alcohol Dependence|January 14, 2020
The Rapidly Changing US Illicit Drug Market and the Potential for an Improved Early Warning System: Evidence from Ohio Drug Crime LabsDaniel Rosenblum, Jay Unick, Daniel Ciccarone
Addiction (Abingdon, England)|December 5, 2018
Illicit fentanyls in the opioid street market: desired or imposed?Sarah G Mars, Daniel Rosenblum, Daniel Ciccarone
Addiction (Abingdon, England)|March 16, 2019
Fentanyl: the many challenges aheadSarah G Mars, Daniel Rosenblum, Daniel Ciccarone
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Clinical and Translational Science|March 2, 2012
Access to core facilities and other research resources provided by the Clinical and Translational Science AwardsDaniel Rosenblum
Current Opinion in Genetics & Development|April 23, 2022
Epithelial-immune crosstalk in health and diseaseDaniel Rosenblum, Shruti Naik
Chest|September 8, 2011
The role of the clinical and translational science awards program in improving the quality and efficiency of clinical researchDaniel Rosenblum, Barbara Alving
Cell Stem Cell|April 2, 2021
New dog, old tricks: Developmental programs resurface in inflammationDaniel Rosenblum, Shruti Naik
Substance Use & Misuse|March 27, 2013
Did the Taliban's opium eradication campaign cause a decline in HIV infections in Russia?Daniel Rosenblum, Maggie Jones
Cancer Letters|August 15, 2013
Omics-based nanomedicine: the future of personalized oncologyDaniel Rosenblum, Dan Peer
Nature Biotechnology|November 13, 2021
RNA delivery with a human virus-like particleAnna Gutkin, Daniel Rosenblum, Dan Peer
Drug and Alcohol Dependence|January 14, 2020
The Rapidly Changing US Illicit Drug Market and the Potential for an Improved Early Warning System: Evidence from Ohio Drug Crime LabsDaniel Rosenblum, Jay Unick, Daniel Ciccarone
Addiction (Abingdon, England)|December 5, 2018
Illicit fentanyls in the opioid street market: desired or imposed?Sarah G Mars, Daniel Rosenblum, Daniel Ciccarone
Addiction (Abingdon, England)|March 16, 2019
Fentanyl: the many challenges aheadSarah G Mars, Daniel Rosenblum, Daniel Ciccarone
Pageof 5